LONG-TERM USE OF BENZODIAZEPINES IN PATIENTS WITH AND WITHOUT PERSONALITY DISORDERS

  • Olivera Žikić
  • Jelena Kostić Univerzitet u Nišu, Medicinski fakultet, Niš, Srbija
  • Jelena Stojanov Special Hospital for Psychiatric Diseases “Gornja Toponica”, Gornja Toponica, Serbia
  • Iva Binić University of Niš, Faculty of Medicine, Department of Psychiatry, Niš, Serbia; University Clinical Center Niš, Clinic of Psychiatry, Niš, Serbia
  • Gordana Nikolić University of Niš, Faculty of Medicine, Department of Psychiatry, Niš, Serbia; University Clinical Center Niš, Serbia Centre for Mental Health
Keywords: benzodiazepine, dependence, personality, withdrawal

Abstract


Personality disorders (PD) are prevalent co-morbid conditions among addicted individuals. Our study aimed to determine whether long-term, continuous use of benzodiazepines (over a year) leads to the development of symptoms of dependence considering the presence or absence of personality disorders. The group consisted of 78 benzodiazepine users who used benzodiazepine as a monotherapy for at least 1 year before a screening. Patients completed a group of questionnaires: a semi-structured questionnaire for sociodemographic data as well as for basic data on the use of benzodiazepines, Wisconsin Personality Inventory, and Benzodiazepine Dependence Self-Report Questionnaire. The group was divided into two subgroups: the group of subjects with personality disorders (60.26%) and those without personality disorders (39.74%). These two groups were mutually compared concerning: (a) correlates of benzodiazepine dependence (problematic use of benzodiazepines, preoccupation with benzodiazepines, lack of compliance, and withdrawal syndrome) and (b) intensity of benzodiazepine dependence. In the whole group, approximately 70% of subjects had positive indicators for physical dependence (lack of compliance due to a rise of tolerance in 73.08% and withdrawal in 70.51% of subjects). The psychological dependence indicator (preoccupation with benzodiazepines) was positive in 94.87% of subjects, as well as for social aspects of dependence (problematic use of BDZs) in 93.59%. The total score, or intensity of benzodiazepine dependence, was statistically higher in the group with personality disorder. Patients with a personality disorder had more frequent and more intensive preoccupation with benzodiazepine and lack of compliance. Co-occurrence of two or more personality disorders increases the intensity of preoccupation with a benzodiazepine. 

References

Andrews G. Comorbidity and the general neurotic syndrome. The British Journal of Psychiatry 1996;168(S30):76-84. [CrossRef][PubMed]

Baillie AJ, Mattick RP. The benzodiazepine dependence questionnaire: development, reliability and validity. The British Journal of Psychiatry 1996;169(3): 276-81. [CrossRef][PubMed]

Canham SL, Gallo J, Simoni-Wastila L. Perceptions of benzodiazepine dependence among women age 65 and older. Journal of gerontological social work 2014;57(8):872-88. [CrossRef][PubMed]

de las Cuevas C, Sanz E, de la Fuente J. Benzodiazepines: more" behavioural" addiction than dependence. Psychopharmacology 2003;167:297-303. [CrossRef][PubMed]

Edinoff AN, Nix CA, Hollier J, Sagrera CE, Delacroix BM, Abubakar T, et al. Benzodiazepines: uses, dangers, and clinical considerations. Neurology international 2021;13(4):594-607. [CrossRef][PubMed]

Fraser R, Isaif L, Teles D, Laporte L. Personality Disorders and Addiction Disorders. In: el-Guebaly N, Carra G, Galanter M, Baldacchino AM, editors. Textbook of Addiction Treatment: International Perspectives. New York City: Springer; 2021. p. 1373-89. [CrossRef]

Goretti S, Sanchéz MS, Borja PL, Rivera GB, Lara MR. The relationship between personality disorders and substance abuse disorders. European Psychiatry 2017;41(S1):S473-4. [CrossRef]

Kan CC, Breteler MH, Timmermans EA, Van der Ven AH, Zitman FG. Scalability, reliability, and validity of the benzodiazepine dependence self-report questionnaire in outpatient benzodiazepine users. Comprehensive psychiatry 1999;40(4):283-91. [CrossRef][PubMed]

Klein MH, Benjamin LS, Rosenfeld R, Treece C, Husted J, Greist JH. The Wisconsin personality disorders inventory: Development, reliability, and validity. Journal of Personality Disorders 1993;7(4):285-303. [CrossRef]

Konopka A, Wysiecka JP, Samochowiec J. Benzodiazepine misuse and addiction. Risk factors and adverse behavioral aspects. In: Preedy VR, editor. Neuropathology of drug addictions and substance misuse, Volume 3: General Processes and Mechanisms, Prescription Medications, Caffeine and Areca, Polydrug Misuse, Emerging Addictions and Non-Drug Addictions. Cambridge (Massachusetts): Academic Press; 2016. p. 327-33. [CrossRef]

Manthey L, Lohbeck M, Giltay EJ, Veena T, Zitman FG, Penninx BW. Correlates of benzodiazepine dependence in the Netherlands Study of Depression and Anxiety. Addiction 2012;107(12):2173-82. [CrossRef][PubMed]

Nordfjærn T, Bjerkeset O, Moylan S, Berk M, Gråwe RW. Clusters of personality traits and psychological symptoms associated with later benzodiazepine prescriptions in the general population: The HUNT Cohort Study. Addictive Behaviors 2013;38(10):2575-80. [CrossRef][PubMed]

Petursson H, Lader MH. Benzodiazepine dependence. British Journal of Addiction 1981;76(2):133-45. [CrossRef][PubMed]

Salzman C, Balter M, Ellinwood E, Gallant DM, Gillin JC, Greenblatt DJ, et al. American Psychiatric Association task force on benzodiazepine dependency, toxicity, and abuse. Washington: American Psychiatric Press; 1990.

Schneider Jr R, Ottoni GL, Carvalho HW, Elisabetsky E, Lara DR. Temperament and character traits associated with the use of alcohol, cannabis, cocaine, benzodiazepines, and hallucinogens: evidence from a large Brazilian web survey. Brazilian Journal of Psychiatry 2015;37:31-9. [CrossRef][PubMed]

Schweizer E, Rickels K, De Martinis N, Case G, Garcia-Espana F. The effect of personality on withdrawal severity and taper outcome in benzodiazepine dependent patients. Psychological Medicine 1998;28(3):713-20. [CrossRef][PubMed]

Smith TL, Klein MH, Benjamin LS. Validation of the Wisconsin personality disorders inventory-IV with the SCID-II. Journal of Personality Disorders 2003;17(3):173-87. [CrossRef][PubMed]

Uhlenhuth EH, DeWit HA, Balter MB, Johanson CE, Mellinger GD. Risks and benefits of long-term benzodiazepine use. Journal of Clinical Psychopharmacology 1988;8(3):161-7. [CrossRef][PubMed]

Umbricht A, Velez ML. Benzodiazepine and nonbenzodiazepine hypnotics (z-drugs): the other epidemic. In: el-Guebaly N, Carra G, Galanter M, Baldacchino AM, editors. Textbook of Addiction Treatment: International Perspectives. New York City: Springer; 2021. p. 141-56. [CrossRef]

Votaw VR, Geyer R, Rieselbach MM, McHugh RK. The epidemiology of benzodiazepine misuse: a systematic review. Drug and alcohol dependence 2019;200:95-114. [CrossRef][PubMed]

Published
2025/02/07
Section
Original article